| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/18/1995 | WO1995013090A1 Improved interferon polymer conjugates |
| 05/18/1995 | WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 05/18/1995 | WO1995013088A1 Stroma-derived stem cell growth factors |
| 05/18/1995 | WO1995013086A1 Cytokine restraining agents |
| 05/18/1995 | WO1995013085A1 Methylated lysine-rich lytic peptides and method of making same by reductive alkylation |
| 05/18/1995 | WO1995013084A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 05/18/1995 | WO1995013083A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 05/18/1995 | WO1995013081A1 Lymphotropic agents and vectors |
| 05/18/1995 | WO1995012979A1 Compositions and methods for transduction of cells |
| 05/18/1995 | DE4431833C1 Prepn. of an anti-haemophilic factor from a cryo-precipitate |
| 05/18/1995 | DE4326821A1 New cancer vaccine based on autologous, transfected tumour cells |
| 05/18/1995 | DE3744826C2 New hybrid protein corresp. to HTLV-3 env and gag determinants |
| 05/18/1995 | CA2183551A1 Gene therapy vector for the treatment of low or defective red blood cell production |
| 05/18/1995 | CA2176378A1 Bcl-2-associated proteins |
| 05/18/1995 | CA2176375A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 05/18/1995 | CA2176284A1 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 |
| 05/18/1995 | CA2176257A1 Reestablishment of ifn-.gamma. inducibility or constitutive expression of mhc class ii in tumor cells |
| 05/18/1995 | CA2176217A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 05/18/1995 | CA2176208A1 Surface membrane proteins and their effect on immune response |
| 05/18/1995 | CA2176133A1 Tomato xyloglucan endo-transglycosylase |
| 05/18/1995 | CA2176115A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 05/18/1995 | CA2176114A1 Cytokines from natural killer or t cells |
| 05/18/1995 | CA2176035A1 Base-modified enzymatic nucleic acid |
| 05/18/1995 | CA2175373A1 Brain-derived membrane-associated crf binding proteins |
| 05/18/1995 | CA2174735A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 05/18/1995 | CA2173731A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
| 05/18/1995 | CA2151059A1 Cathepsin-l-specific inhibitor polypeptide |
| 05/17/1995 | EP0653489A1 Coccidiosis poultry vaccin |
| 05/17/1995 | EP0653154A2 Transgenic animal for alzheimer's disease |
| 05/17/1995 | EP0653064A1 Clinical test for detection of alzheimer's disease |
| 05/17/1995 | EP0652975A1 Assessment of trans-acting factors allelic variation |
| 05/17/1995 | EP0652968A1 Defective adenoviruses and corresponding complementation lines |
| 05/17/1995 | EP0652967A1 Self-assembling replication defective hybrid virus particles |
| 05/17/1995 | EP0652966A1 Method of increasing expression of viral proteins |
| 05/17/1995 | EP0652964A1 $i(K. LACTIS) TRANSALDOLASE GENE PROMOTER AND USE THEREOF |
| 05/17/1995 | EP0652962A1 Expression of recombinant fusion proteins in attenuated bacteria |
| 05/17/1995 | EP0652959A1 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 05/17/1995 | EP0652958A1 Cloning and expression of a lipase modulator gene from pseudomonas pseudoalcaligenes |
| 05/17/1995 | EP0652956A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 05/17/1995 | EP0652955A1 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
| 05/17/1995 | EP0652954A1 A novel gene coding human epidermal growth factor and process for preparing the same |
| 05/17/1995 | EP0652953A1 Morphogenic protein soluble complex and composition thereof |
| 05/17/1995 | EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 05/17/1995 | EP0652951A1 Gdf-1 |
| 05/17/1995 | EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 05/17/1995 | EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON |
| 05/17/1995 | EP0652902A1 DERIVATIVES OF $i(BAUHINIA PURPUREA) LECTIN AND THEIR USE AS LARVICIDES |
| 05/17/1995 | EP0652901A1 Carboxy terminal il-6 muteins |
| 05/17/1995 | EP0652900A1 Thrombin inhibitors |
| 05/17/1995 | EP0652899A1 A fungicidally active compound |
| 05/17/1995 | EP0652898A1 Methods for detecting pre-clinical iddm |
| 05/17/1995 | EP0652897A1 Peptide inhibitors of selectin binding |
| 05/17/1995 | EP0652896A1 Peptide compounds |
| 05/17/1995 | EP0652895A1 Compounds which inhibit hiv replication |
| 05/17/1995 | EP0652893A1 Kininogenase inhibitors |
| 05/17/1995 | EP0652891A1 T-cell membrane inducing factors |
| 05/17/1995 | EP0652889A1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/17/1995 | EP0652888A1 INHIBITION OF $i(CANDIDA) |
| 05/17/1995 | EP0652886A1 Esterification process |
| 05/17/1995 | EP0652798A1 Sorbent families |
| 05/17/1995 | EP0652772A1 Herpesvirus vaccines |
| 05/17/1995 | EP0652765A1 Des-tyr dynorphin analogues |
| 05/17/1995 | EP0652764A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 05/17/1995 | EP0652758A1 Diphtheria toxin vaccines |
| 05/17/1995 | EP0486520B1 Dynorphin analogs specific for kappa opioid receptors |
| 05/17/1995 | EP0482185A4 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 05/17/1995 | EP0395634B1 Htlv-i peptide antigen and assay |
| 05/17/1995 | EP0274482B1 Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 05/17/1995 | CA2135711A1 Cyclic amino acid derivatives |
| 05/16/1995 | US5416260 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
| 05/16/1995 | US5416201 DNAs that code for mouse interleuken 4 |
| 05/16/1995 | US5416197 Antibodies which bind human collapsin |
| 05/16/1995 | US5416195 Polypeptide derivatives of granulocyte colony stimulating factor |
| 05/16/1995 | US5416194 Extracted from horseshoe crab |
| 05/16/1995 | US5416192 Epithelins: novel cysteine-rich growth modulating proteins |
| 05/16/1995 | US5416117 Cyclopropenone derivatives |
| 05/16/1995 | US5416074 Artificial biological membrane |
| 05/16/1995 | US5416073 Replacements and derivatives of terminal amino acid residues increased milk production in cows |
| 05/16/1995 | US5416021 Fibronectin binding protein-encoding DNA |
| 05/16/1995 | US5416017 Cholera toxin gene regulated by tissue-specific promoters |
| 05/16/1995 | US5416016 Method for enhancing transmembrane transport of exogenous molecules |
| 05/16/1995 | US5416013 DNA sequences of polypeptides from genetic engineering |
| 05/16/1995 | US5416009 Nucleotide molecule encoding a specific Onchocerca volvulus antigen for the immunodiagnosis of onchocerciasis |
| 05/16/1995 | US5416007 Enhanced proteolytic cleavage of recombinant fusion proteins |
| 05/16/1995 | US5415995 Diagnostic peptides of human papilloma virus |
| 05/16/1995 | US5415859 Production and use of antheimintic agents and protective antigens |
| 05/16/1995 | CA1335622C Bradykinin analogs containing a non-peptide bond |
| 05/16/1995 | CA1335577C Superoxide dismutase analogs having novel binding properties |
| 05/16/1995 | CA1335575C Isolation and characterisation of genes resistant to anthracycline antibiotics |
| 05/13/1995 | CA2135595A1 Transgenic animal for alzheimer's disease |
| 05/13/1995 | CA2135547A1 Coccidiosis poultry vaccine |
| 05/11/1995 | WO1995012815A1 METHOD OF PREVENTING AGGREGATION OF AMYLOID β-PROTEIN |
| 05/11/1995 | WO1995012814A1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease |
| 05/11/1995 | WO1995012689A1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms |
| 05/11/1995 | WO1995012688A1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
| 05/11/1995 | WO1995012684A1 Methods for controlling sialic acid derivatives in recombinant glycoproteins |
| 05/11/1995 | WO1995012682A2 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/11/1995 | WO1995012679A1 Anti-helminth vaccines |
| 05/11/1995 | WO1995012678A2 Improvements relating to cancer therapy |